Genomic analysis and reconstruction of cefotaxime resistance in Streptococcus pneumoniae

Journal of Antimicrobial Chemotherapy

Volumn 68, Issue 8, 2013, Pages 1718-1727

  Fani, Fereshteh ^a   Brotherton, Marie Christine ^a   Leprohon, Philippe ^a   Ouellette, Marc ^a  

^a LAVAL UNIVERSITY   (Canada)

Author keywords

ABC transporters; Glycosyltransferase; Next generation sequencing; Peptidoglycan deacetylase; S. pneumoniae; Sortase

Indexed keywords

CEFOTAXIME; GLYCOSYLTRANSFERASE; N ACETYLGLUCOSAMINE; N ACETYLGLUCOSAMINE DEACETYLASE; PENICILLIN BINDING PROTEIN; PENICILLIN G; SORTASE; UNCLASSIFIED DRUG;

ANTIBIOTIC RESISTANCE; ANTIBIOTIC SENSITIVITY; ARTICLE; BACTERIAL GENOME; GENE SEQUENCE; GENETIC ANALYSIS; GENETIC ASSOCIATION; GENETIC TRANSFORMATION; IN VITRO STUDY; MINIMUM INHIBITORY CONCENTRATION; MISSENSE MUTATION; NONHUMAN; NONSENSE MUTATION; STREPTOCOCCUS PNEUMONIAE; WILD TYPE;

ABC TRANSPORTERS; GLYCOSYLTRANSFERASE; NEXT-GENERATION SEQUENCING; PEPTIDOGLYCAN DEACETYLASE; S. PNEUMONIAE; SORTASE;

ANTI-BACTERIAL AGENTS; BETA-LACTAM RESISTANCE; CEFOTAXIME; DNA, BACTERIAL; GENES, BACTERIAL; GENOME, BACTERIAL; HUMANS; MOLECULAR SEQUENCE DATA; MUTATION; SEQUENCE ANALYSIS, DNA; STREPTOCOCCUS PNEUMONIAE;

EID: 84880819875     PISSN: 03057453     EISSN: 14602091     Source Type: Journal    
DOI: 10.1093/jac/dkt113     Document Type: Article

References (62)

1. O'Brien KL, Wolfson LJ, Watt JP et al. Burden of disease caused by Streptococcus pneumoniae in children younger than 5 years: global estimates. Lancet 2009; 374: 893-902.
2. Lynch JP III, Zhanel GG. Streptococcus pneumoniae: does antimicrobial resistance matter? Semin Respir Crit Care Med 2009; 30: 210-38.
3. Hakenbeck R, Grebe T, Zahner D et al. b-Lactam resistance in Streptococcus pneumoniae: penicillin-binding proteins and non-penicillin-binding proteins. Mol Microbiol 1999; 33: 673-8.
4. Chambers HF. Penicillin-binding protein-mediated resistance in pneumococci and staphylococci. J Infect Dis 1999; 179 Suppl 2: S353-9.
5. Smith AM, Klugman KP. Amino acid mutations essential to production of an altered PBP 2X conferring high-level b-lactam resistance in a clinical isolate of Streptococcus pneumoniae. Antimicrob Agents Chemother 2005; 49: 4622-7.
6. Stanhope MJ, Lefebure T, Walsh SL et al. Positive selection in penicillin-binding proteins 1a, 2b, and 2x from Streptococcus pneumoniae and its correlation with amoxicillin resistance development. Infect Genet Evol 2008; 8: 331-9.
7. Hakenbeck R, Tornette S, Adkinson NF. Interaction of non-lytic b-lactams with penicillin-binding proteins in Streptococcus pneumoniae. J Gen Microbiol 1987; 133: 755-60.
8. Smith AM, Klugman KP. Alterations in PBP 1A essential for high-level penicillin resistance in Streptococcus pneumoniae. Antimicrob Agents Chemother 1998; 42: 1329-33.
9. Krauss J, Hakenbeck R. A mutation in the D,D-carboxypeptidase penicillin-binding protein 3 of Streptococcus pneumoniae contributes to cefotaxime resistance of the laboratory mutant C604. Antimicrob Agents Chemother 1997; 41: 936-42.
10. Hakenbeck R, Konig A, Kern I et al. Acquisition of five high-Mr penicillin-binding protein variants during transfer of high-level b-lactam resistance from Streptococcus mitis to Streptococcus pneumoniae. J Bacteriol 1998; 180: 1831-40.
11. Smith AM, Feldman C, Massidda O et al. Altered PBP 2A and its role in the development of penicillin, cefotaxime, and ceftriaxone resistance in a clinical isolate of Streptococcus pneumoniae. Antimicrob Agents Chemother 2005; 49: 2002-7.
12. Laible G, Spratt BG, Hakenbeck R. Interspecies recombinational events during the evolution of altered PBP 2x genes in penicillin-resistant clinical isolates of Streptococcus pneumoniae. Mol Microbiol 1991; 5: 1993-2002.
13. Laible G, Hakenbeck R. Penicillin-binding proteins in b-lactam-resistant laboratory mutants of Streptococcus pneumoniae. Mol Microbiol 1987; 1: 355-63.
14. Chesnel L, Carapito R, Croize J et al. Identical penicillin-binding domains in penicillin-binding proteins of Streptococcus pneumoniae clinical isolates with different levels of b-lactam resistance. Antimicrob Agents Chemother 2005; 49: 2895-902.
15. Filipe SR, Tomasz A. Inhibition of the expression of penicillin resistance in Streptococcus pneumoniae by inactivation of cell wall muropeptide branching genes. Proc Natl Acad Sci USA 2000; 97: 4891-6.
16. Smith AM, Klugman KP. Alterations in MurM, a cell wall muropeptide branching enzyme, increase high-level penicillin and cephalosporin resistance in Streptococcus pneumoniae. Antimicrob Agents Chemother 2001; 45: 2393-6.
17. Tait-Kamradt AG, Cronan M, Dougherty TJ. Comparative genome analysis of high-level penicillin resistance in Streptococcus pneumoniae. Microb Drug Resist 2009; 15: 69-75.
18. Crisostomo MI, Vollmer W, Kharat AS et al. Attenuation of penicillin resistance in a peptidoglycan O-acetyl transferase mutant of Streptococcus pneumoniae. Mol Microbiol 2006; 61: 1497-509.
19. Grebe T, Paik J, Hakenbeck R. A novel resistance mechanism against b-lactams in Streptococcus pneumoniae involves CpoA, a putative glycosyltransferase. J Bacteriol 1997; 179: 3342-9.
20. Dias R, Felix D, Canica M et al. The highly conserved serine threonine kinase StkP of Streptococcus pneumoniae contributes to penicillin susceptibility independently from genes encoding penicillin-binding proteins. BMC Microbiol 2009; 9: 121.
21. Guenzi E, Gasc AM, Sicard MA et al. A two-component signal-transducing system is involved in competence and penicillin susceptibility in laboratory mutants of Streptococcus pneumoniae. Mol Microbiol 1994; 12: 505-15.
22. Soualhine H, Brochu V, Menard F et al. A proteomic analysis of penicillin resistance in Streptococcus pneumoniae reveals a novel role for PstS, a subunit of the phosphate ABC transporter. Mol Microbiol 2005; 58: 1430-40.
23. Fani F, Leprohon P, Legare D et al. Whole genome sequencing of penicillin resistant Streptococcus pneumoniae reveals mutations in penicillin-binding proteins and in a putative iron permease. Genome Biology 2011; 12: R115.
24. Mwangi MM, Wu SW, Zhou Y et al. Tracking the in vivo evolution of multidrug resistance in Staphylococcus aureus by whole-genome sequencing. Proc Natl Acad Sci USA 2007; 104: 9451-6.
25. Feng J, Lupien A, Gingras H et al. Genome sequencing of linezolid-resistant Streptococcus pneumoniae mutants reveals novel mechanisms of resistance. Genome Res 2009; 19: 1214-23.
26. Albert TJ, Dailidiene D, Dailide G et al. Mutation discovery in bacterial genomes: metronidazole resistance in Helicobacter pylori. Nat Methods 2005; 2: 951-3.
27. Billal DS, Feng J, Leprohon P et al. Whole genome analysis of linezolid resistance in Streptococcus pneumoniae reveals resistance and compensatory mutations. BMC Genomics 2011; 12: 512.
28. Sauerbier J, Maurer P, Rieger M et al. Streptococcus pneumoniae R6 interspecies transformation: genetic analysis of penicillin resistance determinants and genome-wide recombination events. Mol Microbiol 2012; 86: 692-706.
29. Munoz R, Dowson CG, Daniels M et al. Genetics of resistance to third-generation cephalosporins in clinical isolates of Streptococcus pneumoniae. Mol Microbiol 1992; 6: 2461-5.
30. Martineau F, Picard FJ, Lansac N et al. Correlation between the resistance genotype determined by multiplex PCR assays and the antibiotic susceptibility patterns of Staphylococcus aureus and Staphylococcus epidermidis. Antimicrob Agents Chemother 2000; 44: 231-8.
31. Tomasz A, Hotchkiss RD. Regulation of the transformability of pneumococcal cultures by macromolecular cell products. Proc Natl Acad Sci USA 1964; 51: 480-7.
32. Sung CK, Li H, Claverys JP et al. An rpsL cassette, janus, for gene replacement through negative selection in Streptococcus pneumoniae. Appl Environ Microbiol 2001; 67: 5190-6.
33. Hoskins J, Alborn WE Jr, Arnold J et al. Genome of the bacterium Streptococcus pneumoniae strain R6. J Bacteriol 2001; 183: 5709-17.
34. Li H, Durbin R. Fast and accurate short read alignment with Burrows-Wheeler transform. Bioinformatics 2009; 25: 1754-60.
35. Li H, Handsaker B, Wysoker A et al. The Sequence Alignment/Map format and SAMtools. Bioinformatics 2009; 25: 2078-9.
36. Zahner D, Grebe T, Guenzi E et al. Resistance determinants for b-lactam antibiotics in laboratory mutants of Streptococcus pneumoniae that are involved in genetic competence. Microb Drug Resist 1996; 2: 187-91.
37. Jabes D, Tomasz A. Lytic and bactericidal activity of FCE 22101. J Antimicrob Chemother 1989; 23 Suppl C: 75-83.
38. Liu HH, Tomasz A. A mutant of Streptococcus pneumoniae that exhibits thermosensitive penicillin tolerance and the paradoxical effect. J Gen Microbiol 1987; 133: 1611-8.
39. Mouz N, Di Guilmi AM, Gordon E et al. Mutations in the active site of penicillin-binding protein PBP2x from Streptococcus pneumoniae. Role in the specificity for b-lactam antibiotics. J Biol Chem 1999; 274: 19175-80.
40. Mouz N, Gordon E, Di Guilmi AM et al. Identification of a structural determinant for resistance to b-lactam antibiotics in Gram-positive bacteria. Proc Natl Acad Sci USA 1998; 95: 13403-6.
41. Pernot L, Chesnel L, Le Gouellec A et al. A PBP2x from a clinical isolate of Streptococcus pneumoniae exhibits an alternative mechanism for reduction of susceptibility to b-lactam antibiotics. J Biol Chem 2004; 279: 16463-70.
42. Chesnel L, Zapun A, Mouz N et al. Increase of the deacylation rate of PBP2x from Streptococcus pneumoniae by single point mutations mimicking the class A b-lactamases. Eur J Biochem 2002; 269: 1678-83.
43. Maurer P, Koch B, Zerfass I et al. Penicillin-binding protein 2x of Streptococcus pneumoniae: three new mutational pathways for remodelling an essential enzyme into a resistance determinant. J Mol Biol 2008; 376: 1403-16.
44. Asahi Y, Takeuchi Y, Ubukata K. Diversity of substitutions within or adjacent to conserved amino acid motifs of penicillin-binding protein 2X in cephalosporin-resistant Streptococcus pneumoniae isolates. Antimicrob Agents Chemother 1999; 43: 1252-5.
45. Coffey TJ, Daniels M, McDougal LK et al. Genetic analysis of clinical isolates of Streptococcus pneumoniae with high-level resistance to expanded-spectrum cephalosporins. Antimicrob Agents Chemother 1995; 39: 1306-13.
46. Sanbongi Y, Ida T, Ishikawa M et al. Complete sequences of six penicillin-binding protein genes from 40 Streptococcus pneumoniae clinical isolates collected in Japan. Antimicrob Agents Chemother 2004; 48: 2244-50.
47. Grebe T, Hakenbeck R. Penicillin-binding proteins 2b and 2x of Streptococcus pneumoniae are primary resistance determinants for different classes of b-lactam antibiotics. Antimicrob Agents Chemother 1996; 40: 829-34.
48. Sifaoui F, Kitzis MD, Gutmann L. In vitro selection of one-step mutants of Streptococcus pneumoniae resistant to different oral b-lactam antibiotics is associated with alterations of PBP2x. Antimicrob Agents Chemother 1996; 40: 152-6.
49. Gordon E, Mouz N, Duee E et al. The crystal structure of the penicillin-binding protein 2x from Streptococcus pneumoniae and its acyl-enzyme form: implication in drug resistance. J Mol Biol 2000; 299: 477-85.
50. Du Plessis M, Smith AM, Klugman KP. Analysis of penicillin-binding protein lb and 2a genes from Streptococcus pneumoniae. Microb Drug Resist 2000; 6: 127-31.
51. Zhao G, Meier TI, Hoskins J et al. Identification and characterization of the penicillin-binding protein 2a of Streptococcus pneumoniae and its possible role in resistance to b-lactam antibiotics. Antimicrob Agents Chemother 2000; 44: 1745-8.
52. Reichmann P, Konig A, Marton A et al. Penicillin-binding proteins as resistance determinants in clinical isolates of Streptococcus pneumoniae. Microb Drug Resist 1996; 2: 177-81.
53. Vollmer W, Tomasz A. The pgdA gene encodes for a peptidoglycan N-acetylglucosamine deacetylase in Streptococcus pneumoniae. J Biol Chem 2000; 275: 20496-501.
54. Vollmer W, Tomasz A. Peptidoglycan N-acetylglucosamine deacetylase, a putative virulence factor in Streptococcus pneumoniae. Infect Immun 2002; 70: 7176-8.
55. Clancy KW, Melvin JA, McCafferty DG. Sortase transpeptidases: insights into mechanism, substrate specificity, and inhibition. Biopolymers 2010; 94: 385-96.
56. Kharat AS, Tomasz A. Inactivation of the srtA gene affects localization of surface proteins and decreases adhesion of Streptococcus pneumoniae to human pharyngeal cells in vitro. Infect Immun 2003; 71: 2758-65.
57. Chen S, Paterson GK, Tong HH et al. Sortase A contributes to pneumococcal nasopharyngeal colonization in the chinchilla model. FEMS Microbiol Lett 2005; 253: 151-4.
58. McAleese F, Wu SW, Sieradzki K et al. Overexpression of genes of the cell wall stimulon in clinical isolates of Staphylococcus aureus exhibiting vancomycin-intermediate-S. aureus-type resistance to vancomycin. J Bacteriol 2006; 188: 1120-33.
59. Edman M, Berg S, Storm P et al. Structural features of glycosyltransferases synthesizing major bilayer and nonbilayer-prone membrane lipids in Acholeplasma laidlawii and Streptococcus pneumoniae. J Biol Chem 2003; 278: 8420-8.
60. Garvey MI, Baylay AJ, Wong RL et al. Overexpression of patA and patB, which encode ABC transporters, is associated with fluoroquinolone resistance in clinical isolates of Streptococcus pneumoniae. Antimicrob Agents Chemother 2010; 55: 190-6.
61. Marrer E, Schad K, Satoh AT et al. Involvement of the putative ATP-dependent efflux proteins PatA and PatB in fluoroquinolone resistance of a multidrug-resistant mutant of Streptococcus pneumoniae. Antimicrob Agents Chemother 2006; 50: 685-93.
62. Robertson GT, Doyle TB, Lynch AS. Use of an efflux-deficient streptococcus pneumoniae strain panel to identify ABC-class multidrug transporters involved in intrinsic resistance to antimicrobial agents. Antimicrob Agents Chemother 2005; 49: 4781-3.